secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001193125-25-028691
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences prices $200M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Priced public offering of 35.7M shares at $4.03/share and pre-funded warrants for 13.9M shares at $4.029 each; gross proceeds ~$200M.
- Net proceeds estimated at $187.5M after underwriting discounts and expenses; offering expected to close Feb 19, 2025.
- Investors include Adage Capital Partners, Bain Capital Life Sciences, Invus, Perceptive Advisors, RA Capital Management, others.
- Jefferies, Leerink Partners, William Blair act as joint book-runners; H.C. Wainwright as lead manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312525028691/0001193125-25-028691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312525028691/d908068d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-028691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer